1273. Efficacies and side effects of medicinal plants used by patients with cancer in Morocco: A retrospective treatment-outcome study. Cancer Juniperus oxycedrusPrunus armeniacaPrunus armeniaca Aboufaras M, Selmaoui K and Ouzennou N (2023). J Ethnopharmacol. DOI: 10.1016/j.jep.2022.115783 PubMed: 36209952
1274. Sesquiterpenoid lactones as potential anti-cancer agents: an update on molecular mechanisms and recent studies. Cancer Spilanthes acmella Dhyani P et al (2022). Cancer Cell Int. DOI: 10.1186/s12935-022-02721-9 PubMed: 36207736
1275. Investigation on the efficiency of Brucea javanica oil emulsion injection with chemotherapy for treating malignant pleural effusion: A meta-analysis of randomized controlled trials. Cancer Brucea javanica Shi R et al (2022). Front Pharmacol. DOI: 10.3389/fphar.2022.998218 PubMed: 36188623
1276. Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells. Cancer Hibiscus sabdariffa Malacrida A et al (2022). Biochem Biophys Rep. DOI: 10.1016/j.bbrep.2022.101353 PubMed: 36186735
1277. Curculigoside Represses the Proliferation and Metastasis of Osteosarcoma via the JAK/STAT and NF-κB Signaling Pathways. CancerImmunology Curculigo orchioides Gaertn. Guo H et al (2022). Biol Pharm Bull. DOI: 10.1248/bpb.b22-00311 PubMed: 36184504
1278. Origanum majorana essential oil decreases lung tumor growth and metastasis in vitro and in vivo. CancerPhytochemistry Origanum majorana Arafat K et al (2022). Biomed Pharmacother. DOI: 10.1016/j.biopha.2022.113762 PubMed: 36182733
1279. Biosynthesis of silver nanoparticles using Citrus hystrix leaf extract and evaluation of its anticancer efficacy against HeLa cell line. Cancer Citrus hystrix Srimurugan S et al (2022). Drug Dev Ind Pharm. DOI: 10.1080/03639045.2022.2130352 PubMed: 36165580
1280. Network pharmacology-based investigation and experimental validation of the mechanism of scutellarin in the treatment of acute myeloid leukemia. Cancer Scutellaria barbataScutellaria lateriflora Huang Z et al (2022). Front Pharmacol. DOI: 10.3389/fphar.2022.952677 PubMed: 36160389